Trial site
Velocity Clinical Research, Syracuse
- 7running trials
- 11closed trials
The trials here
What the 18 trials at this site are about, from their registry records.
- Conditions
- Obesity6 trials
- Alzheimer disease5 trials
- Diabetic neuropathy3 trials
- Mild cognitive impairment3 trials
- Type 2 diabetes3 trials
- Chronic kidney disease1 trial
- Gastroparesis1 trial
- Phase
- Phase 39 trials
- Phase 27 trials
- Status
- Completed10 trials
- Active, not recruiting3 trials
- Recruiting3 trials
- Enrolling by invitation1 trial
- Terminated1 trial
- Lead sponsor
- Eli Lilly and Company7 trials
- Vertex Pharmaceuticals Incorporated3 trials
- Cognito Therapeutics, Inc.2 trials
- ModernaTX, Inc.2 trials
- CinDome Pharma, Inc.1 trial
- and 3 more
Running trials
Recruiting
Active, not recruiting
Recruiting
Enrolling by invitation
Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
Recruiting
Active, not recruiting
Masupirdine for the Treatment of Agitation in Dementia of the Alzheimer's Type
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Diabetic neuropathy2 recruiting
- Alzheimer disease1 recruiting
- Mild cognitive impairment1 recruiting
- Obesity1 recruiting
Closed trials
Terminated
A Study of LY3549492 in Adults With Obesity or Overweight With Type 2 Diabetes
Completed
Completed
Completed
A Study of mRNA-1010 Compared With a Licensed Influenza Vaccine in Adults ≥50 Years of Age
Completed
A Study of LY3841136 Compared With Placebo in Adult Participants With Obesity or Overweight
Completed
Completed
Completed
Completed
Completed
A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study)
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026